<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Selective Antagonists of the Bronchiolar Epithelial NF-kB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Bing</forename><surname>Tian</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Sealy Center for Molecular Medicine</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zhiqing</forename><surname>Liu</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jun</forename><surname>Yang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Sealy Center for Molecular Medicine</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Erik</forename><surname>Rytting</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jia</forename><surname>Zhou</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Sealy Center for Molecular Medicine</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Institute for Translational Sciences</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Allan</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
							<email>abrasier@wisc.edu</email>
							<affiliation key="aff5">
								<orgName type="department">School of Medicine and Public Health</orgName>
								<orgName type="institution">University of Wisconsin</orgName>
								<address>
									<postCode>53715</postCode>
									<settlement>Madison</settlement>
									<region>WI</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Lead Contact</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hong</forename><surname>Sun</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yingxin</forename><surname>Zhao</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Sealy Center for Molecular Medicine</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Institute for Translational Sciences</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maki</forename><surname>Wakamiya</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institute for Translational Sciences</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Haiying</forename><surname>Chen</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<postCode>77555</postCode>
									<settlement>Galveston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Selective Antagonists of the Bronchiolar Epithelial NF-kB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">0067D58FE2683A8D9C641D927B1B9D5C</idno>
					<idno type="DOI">10.1016/j.celrep.2018.03.106</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:28+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Highlights d Innate stimuli activate NF-kB/RelA and indirectly induce BRD4 HAT activity d Activity of the RelA-BRD4 complex controls neutrophil chemokine production d The RelA-BRD4 pathway in Scgb1a1-expressing cells is required for airway inflammation d Highly selective inhibitors of BRD4 reduce neutrophilic airway inflammation</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Approximately 384 million people worldwide are affected by chronic obstructive pulmonary disease (COPD), a heterogeneous, environmentally caused lung disease where inflammation accelerates irreversible remodelling of the airways <ref type="bibr" target="#b32">(Rabe et al., 2007)</ref>.</s><s>COPD is an age-related disease that typically begins at middle age and increases in prevalence, severity, and mortality thereafter (Centers for Disease Control and Prevention (CDC), 2008).</s><s>Consequently, COPD is the fourth largest cause of death globally and the third largest cause in the United States.</s><s>The course of COPD is punctuated by intermittent, acute exacerbations of obstructive symptoms.</s><s>Exacerbations reduce exercise capacity and quality of life and increase health care costs <ref type="bibr" target="#b11">(Donaldson et al., 2005;</ref><ref type="bibr" target="#b34">Seemungal et al., 1998)</ref>.</s></p><p><s>Respiratory RNA viral infections are responsible for over half of the acute decompensations in patients with COPD <ref type="bibr" target="#b41">(Wedzicha, 2004)</ref>.</s><s>Viral pathogen-associated patterns (PAMPs), notably double-stranded RNA (dsRNA) produced by active infection from these ubiquitous viruses, trigger leukocytic inflammation, mucous production, and airway hyperreactivity.</s><s>PAMPs are detected in the airway by membrane-associated Toll-like receptor 3 (TLR-3) and intracellular retinoic acid inducible gene I (RIG-I), two receptors that trigger transcription factors signaling the innate immune response <ref type="bibr" target="#b0">(Alexopoulou et al., 2001;</ref><ref type="bibr" target="#b2">Bertolusso et al., 2014)</ref>.</s><s>Of these, nuclear factor kB (NF-kB) plays a major role in innate inflammation, controlling the expression of inflammatory chemokines as well as the mucosal interferons (IFNs) <ref type="bibr">(Brasier et al., 2011;</ref><ref type="bibr" target="#b39">Tian et al., 2017)</ref>.</s><s>NF-kB activation involves RelA release from cytoplasmic inhibitors coupled with a nuclearoxidative-stress-induced serine phosphorylation, promoting RelA binding to bromodomain-containing protein 4 (BRD4) <ref type="bibr">(Brasier et al., 2011;</ref><ref type="bibr" target="#b39">Tian et al., 2017)</ref>.</s><s>Through sequence-specific binding, NF-kB recruits BRD4 to latent innate genes, promoting their rapid expression by a process of transcriptional elongation <ref type="bibr" target="#b29">(Nowak et al., 2008;</ref><ref type="bibr" target="#b37">Tian et al., 2013)</ref>.</s><s>In this manner, the nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NF-kB)-BRD4 complex binds and directly activates immediate-early inflammatory CXC chemokines and indirectly activates mucosal type I and III IFNs via the IFN regulatory factor (IRF)-RIG-I pattern recognition receptor ''cross-talk pathway'' <ref type="bibr" target="#b12">(Fang et al., 2015)</ref>.</s><s>Upon secretion, these cytokines activate airway dendritic cells and innate lymphocytes to initiate the pulmonary adaptive immune response <ref type="bibr" target="#b18">(Holt and Strickland, 2010</ref>).</s></p><p><s>An unresolved question is the identity of the major sentinel cell of the airway responsible for detecting viral PAMPs.</s><s>Airway epithelial cells dynamically respond to viral patterns in a celltype-specific pattern by synthesizing and secreting over 400 proteins, including CXC and CC-type chemokines, type I and III IFNs, and IFN-stimulated genes (ISGs) <ref type="bibr" target="#b45">(Zhao et al., 2017)</ref>.</s><s>Similarly, resident alveolar macrophages synthesize cytokine mediators that play roles in initial antiviral defense and inflammation <ref type="bibr" target="#b23">(Kolli et al., 2014)</ref>.</s><s>Recent work has also implicated the role of group 2 innate lymphoid cells in the host response to viruses <ref type="bibr" target="#b30">(Peebles et al., 2001)</ref>.</s><s>To provide greater insight into the role of the epithelial cell as a sentinel cell responding to viral PAMPs, we developed a conditional knockout (CKO) mouse by selectively deleting RelA in tracheobronchiolar cells and challenged them with poly(I:C), a viral pattern that simulates acute RNA virus infections in COPD <ref type="bibr" target="#b15">(Harris et al., 2013;</ref><ref type="bibr" target="#b35">Stowell et al., 2009)</ref>.</s><s>We observed that poly(I:C) induces mucosal BRD4-dependent histone acetyltransferase (HAT) activity on H3K122 and BRD4dependent phosphorylation of Ser2 on the RNA polymerase II (Pol II) C-terminal domain (CTD).</s><s>Interestingly, both of these activities were blocked by RelA silencing in cellulo and in vivo.</s><s>To selectively study the functional role of BRD4 in vivo, we utilized a structure-based design approach to develop two BRD4-selective inhibitors that bind to the BRD4 bromodomains (BDs) with nanomolar affinity.</s><s>BRD4 inhibition also completely blocked poly(I:C)-induced inflammatory gene programs in cellulo and airway inflammation and neutrophil recruitment in vivo.</s><s>Our studies indicate that the tracheobronchiolar epithelial cell is an innate sensor to viral patterns and validate BRD4 as a rational target to prevent virus-induced lung inflammation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NF-kB/RelA Mediates TLR3-Induced Neutrophil Chemokine Expression in Bronchiolar Cells</head><p><s>To extend our earlier studies that NF-kB-BRD4 signaling mediates the RIG-I-initiated antiviral innate response <ref type="bibr" target="#b12">(Fang et al., 2015;</ref><ref type="bibr" target="#b39">Tian et al., 2017)</ref>, we evaluated the role of NF-kB/RelA in TLR3-mediated activation of neutrophilic chemoattractant secretion.</s><s>This model used telomerase-immortalized human small airway epithelial cells (hSAECs), differentiated epithelial cells that exhibit similar innate responses as primary SAECs whose stable phenotype enables genomic manipulation.</s><s>hSAECs permit the study of signaling pathways relevant to those in vivo <ref type="bibr" target="#b39">(Tian et al., 2017;</ref><ref type="bibr" target="#b45">Zhao et al., 2017)</ref>.</s><s>To establish stable RelA-deficient hSAECs, we used CRISPR/Cas9 genome editing to introduce a frameshift mutation in exon 4 of RelA (Figure <ref type="figure" target="#fig_0">1A</ref>), resulting in a complete absence of the 65-kDa RelA by western immunoblot (Figure <ref type="figure" target="#fig_0">1B</ref>).</s><s>Wild-type (RelA +/+ ) or RelA À/À hSAECs were stimulated with poly(I:C), and neutrophilic chemokine expression was quantified.</s><s>In RelA +/+ cells, poly(I:C) induced an 85-fold induction of CSF3/G-CSF mRNA after 6 hr of stimulation; this induction was reduced to less than 12-fold in RelA À/À hSAECs (Figure <ref type="figure" target="#fig_0">1C</ref>).</s><s>Similarly, the 57-fold induction of CSF2/ GM-CSF, the 16-fold induction of CXCL1/Groa, the 10-fold induction of CXCL2/Grob, the 50-fold induction of CXCL8/IL8, the 470-fold induction of CCL2/MCP1, and the 4,200-fold induction of CCL5/RANTES were all significantly reduced by RelA silencing (Figure <ref type="figure" target="#fig_0">1C</ref>).</s><s>These data indicated that the neutrophilic chemokine response in hSAECs was RelA dependent.</s></p><p><s>RelA Is Required for Poly(I:C)-Induced RNA Pol II Phosphorylation and BRD4 Histone Acetyl Transferase Activity We earlier found that intracellular respiratory syncytial virus (RSV) replication promoted the formation of a ternary RelA-BRD4-CDK9 complex <ref type="bibr">(Brasier et al., 2011;</ref><ref type="bibr" target="#b39">Tian et al., 2017)</ref>.</s><s>RelA +/+ or RelA À/À hSAECs were stimulated with extracellular poly(I:C) and analyzed by immunofluorescence confocal microscopy (IFCM).</s><s>Poly(I:C) stimulation induced RelA nuclear translocation in 88% of RelA +/+ cells and induced phospho-Ser 276 RelA.</s><s>Both signals were abolished by RelA silencing, confirming knockdown and staining specificity (Figures <ref type="figure" target="#fig_0">1D and 1E</ref>).</s></p><p><s>Our previous work showed that RIG-I was required for RSV induction of BRD4 HAT activity forming acetylated H3 on lysine (Lys) (K) 122 <ref type="bibr" target="#b39">(Tian et al., 2017)</ref>, a post-translational modification that destabilizes nucleosomes, promoting transcriptional elongation by enabling RNA Pol II to traverse nucleosome-rich coding sequences <ref type="bibr" target="#b9">(Devaiah et al., 2016)</ref>.</s><s>We found that poly(I:C) produced a 14.5-fold increase of nuclear H3K122 acetylation (Ac) that was also inhibited in the RelA-deficient hSAECs (Figures <ref type="figure" target="#fig_0">1D and 1E</ref>).</s></p><p><s>Besides its HAT activity forming acetylated H3K122 <ref type="bibr" target="#b9">(Devaiah et al., 2016)</ref>, BRD4 is also an atypical kinase that phosphorylates Ser2 CTD RNA Pol II <ref type="bibr">(Devaiah et al., 2012)</ref>.</s><s>We found that poly(I:C) treatment induced a 20-fold increase in phospho-Ser 2 CTD RNA Pol II formation in wild-type cells, an activation that was silenced in the RelA-depleted cells (Figure <ref type="figure" target="#fig_0">1D and 1E</ref>).</s><s>These data indicate that RelA is required for global activation of atypical BRD4 HAT activity and phosphorylation of Ser 2 in the RNA Pol II CTD by extracellular poly(I:C).</s></p><p><s>RelA Is Required for BRD4 HAT Activity and RNA Pol II Phosphorylation in Response to TNF-a We next asked whether RelA-mediated BRD4 HAT activity and phospho-Ser 2 CTD RNA Pol II formation were inducible in a stimulus-independent mechanism by other innate activators.</s><s>We examined the effects of tumor necrosis factor a (TNF-a), a monokine that activates RelA via TNFRI <ref type="bibr" target="#b36">(Tian et al., 2005)</ref>, that produces nuclear translocation in 90% of cells (Figure <ref type="figure" target="#fig_0">S1</ref>).</s><s>TNF-a stimulation induced a 4-fold increase in H3K122 Ac and a 15-fold increase in phospho-Ser2 CTD RNA Pol II formation that was also dependent on RelA (Figure <ref type="figure" target="#fig_0">S1</ref>).</s><s>Similarly, TNFa-induced expression of CSF3/G-CSF, CSF2/GM-CSF, CXCL1/ Groa, CXCL2/Grob, CXCL8/IL8, and CCL2/MCP1 chemokines were blocked by RelA silencing (Figure <ref type="figure" target="#fig_0">S1</ref>).</s><s>Together, these data indicate that RelA is required for global inducible regulation of atypical BRD4 HAT activity and RNA Pol II kinase activity in response to viral and cytokine innate activators.</s></p><p><s>BRD4 HAT Activity Is Required for Formation of Phospho-Ser 2 CTD RNA Pol II Formation and Acetylation of H3K122 as well as Transcriptional Activation BRD4 is an RNA Pol II serine kinase that functions in cooperation with CDK9 <ref type="bibr">(Devaiah and Singer, 2012)</ref>.</s><s>To examine the individual contributions of endogenous BRD4 and CDK9 in poly(I:C)-induced   acetylation of H3K122 and formation of phospho-Ser 2 CTD RNA Pol II, we depleted endogenous BRD4 or CDK9 separately using siRNA mediated transfection.</s><s>We observed that BRD4 silencing blocked both poly(I:C)-induced induction of H3K122 Ac and phospho-Ser 2 CTD RNA Pol II formation by IFCM (Figure <ref type="figure" target="#fig_2">2A</ref>).</s><s>Conversely, CDK9 silencing inhibited phospho-Ser2 CTD RNA Pol II activation to a similar extent as seen by BRD4 silencing but did not affect induction of H3K122 Ac (Figure <ref type="figure" target="#fig_2">2A</ref>).</s><s>Both BRD4 and CDK9 silencing reduced the expression of the RelA-dependent genes IL6, IL8, Grob, and MCP1 (Figure <ref type="figure" target="#fig_2">2B</ref>).</s></p><p><s>To directly examine the role of BRD4 kinase or HAT domains in regulating transcription, previously characterized FLAG epitopetagged BRD4 wild-type (WT) or mutants were transfected into hSAECs.</s><s>The BRD4DN mutation deletes both the NH 2 terminal kinase domain and the acetyl-CoA binding domains, whereas the BRD4DHAT mutation destroys its HAT activity <ref type="bibr" target="#b9">(Devaiah et al., 2016)</ref>.</s><s>Consistent with the earlier observations <ref type="bibr" target="#b9">(Devaiah et al., 2016)</ref>, BRD4 WT overexpression itself significantly increased the formation of H3K122 Ac and phospho-Ser 2 CTD RNA Pol II in FLAG-expressing cells (Figures <ref type="figure" target="#fig_2">2C and 2D</ref>).</s><s>Correspondingly, BRD4 WT overexpression also activated of RelA-dependent IL6, IL8, and Grob gene expression (Figure <ref type="figure" target="#fig_2">2E</ref>).</s><s>By contrast, expression of either BRD4DN or BRD4DHAT interfered with H3K122 Ac in FLAG-expressing cells (Figure <ref type="figure" target="#fig_2">2C</ref>).</s><s>Similarly, inducible formation of phospho-Ser 2 RNA Pol II CTD was blocked, as was induction of RelA-dependent genes (Figures <ref type="figure" target="#fig_2">2D and 2E</ref>).</s><s>We conclude that both BRD4 kinase and HAT activities are required for formation of H3K122 Ac, phospho-Ser 2 CTD RNA Pol II, and RelA-dependent transcriptional activation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conditional Knockout of RelA in Secretoglobin-Expressing Epithelial Cells</head><p><s>Recognizing that unscheduled RelA activity affects normal lung branching <ref type="bibr" target="#b1">(Benjamin et al., 2010)</ref>, we generated an epithelial-specific CKO by crossing our novel NH2-terminal RelA fl/fl mouse <ref type="bibr" target="#b20">(Ijaz et al., 2016)</ref> with an epithelial-specific secretoglobin family 1A member 1 (Scgb1a1) promoter-driven inducible Cre recombinase/estrogen receptor fusion protein (CreER TM ) transgenic mouse (Figure <ref type="figure" target="#fig_4">3A</ref>).</s><s>Scgb1a1-CreER TM expresses Cre selectively in the basal cells of the tracheal and bronchiolar epithelium <ref type="bibr" target="#b33">(Rawlins et al., 2009)</ref>.</s><s>This inducible RelA CKO enabled us to disrupt NF-kB signaling activated by either the canonical (Ik-Ba) pathway or the cross-talk (RelA-NF-kB2) pathway <ref type="bibr" target="#b26">(Liu et al., 2008)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Confirmation of RelA CKO in the Scgb1a1-Expressing Bronchiolar Epithelium</head><p><s>We evaluated the effectiveness of the bronchiolar epithelial RelA CKO on acute poly(I:C)-induced airway inflammation.</s></p><p><s>Scgb1a1-CreER TM 3 RelA fl/fl mice were treated with oil (control) or tamoxifen (TMX) to excise RelA.</s><s>To confirm selective recombination in the bronchiolar epithelium, we crossed the Scgb1a1-CreER TM 3 RelA fl/fl mice with the double-fluorescent dimeric tomato (mT)/membrane EGFP (mG) mouse <ref type="bibr" target="#b28">(Muzumdar et al., 2007)</ref>.</s><s>In mice harboring the mT/mG alleles, the presence of active Cre leads to excision of the tandem dimer tomato reporter and expression of a membrane-localized EGFP.</s><s>The Scgb1a1-CreER TM 3 RelA fl/fl 3 mT/mG mice were then exposed to oil or TMX for 10 days; 2 weeks later, the lungs were analyzed by IFCM.</s><s>In oil-treated mice, uniform staining of the tomato reporter was observed throughout the bronchioles, identified as airspaces lined by single-layered epithelial cells without surrounding tracheal cartilage (Figure <ref type="figure" target="#fig_4">3B</ref>).</s><s>By contrast, EGFP fluorescence was observed in the epithelial layer of the TMX-treated mice, confirming functional Cre expression (Figure <ref type="figure" target="#fig_4">3B</ref>).</s><s>RelA expression was significantly reduced in these cells after TMX treatment (Figures <ref type="figure" target="#fig_4">3C and 3D</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Bronchiolar Epithelial RelA CKO Blocks Poly(I:C)-Induced Leukocytic Inflammation</head><p><s>To determine the role of the epithelium as a sentinel cell detecting viral luminal PAMPs, we challenged oil-or TMX-treated Scgb1a1-CreER TM 3 RelA fl/fl with intranasal poly(I:C).</s><s>Poly(I:C) increased the leukocyte number $5-times greater than that of PBS challenge control in oil-treated mice, an induction that was effectively inhibited by TMX treatment (Figure <ref type="figure" target="#fig_4">3E</ref>).</s><s>Also, the percentage of bronchoalveolar lavage fluid (BALF) neutrophils increased from 1% to 56.3% in oil-treated mice exposed to poly(I:C), and this induction was significantly reduced to 9.7% in TMX-treated mice (Figure <ref type="figure" target="#fig_4">3E</ref>).</s></p><p><s>Correspondingly, bronchiolar RelA CKO had a dramatic effect on poly(I:C)-induced BALF chemokine expression.</s><s>In comparison to PBS-treated mice, where interleukin 6 (IL-6) protein abundance was below the lower limit of detection, poly(I:C) induced IL-6 to 193 pg/mL, an increase largely reduced by TMX (Figure <ref type="figure" target="#fig_4">3F</ref>).</s><s>Similar poly(I:C)-induced expression patterns were seen for KC, IFN-b, CCL2/MCP1, granulocyte colony stimulating factor (G-CSF), MIP1a, MIP1b, and CCL5/RANTES.</s><s>In TMXtreated animals, poly(I:C)-induced values were all significantly reduced (p &lt; 0.01; Figure <ref type="figure" target="#fig_4">3F</ref>).</s><s>We confirmed that these reductions in chemokine expression were mediated by inhibition of mRNA expression (Figure <ref type="figure" target="#fig_2">S2</ref>).</s><s>In addition to the effects on neutrophilic chemokines, we recently described RelA to be a master regulator of mucosal IFN response through a cross-talk pathway <ref type="bibr" target="#b12">(Fang et al., 2015;</ref><ref type="bibr" target="#b39">Tian et al., 2017)</ref>.</s><s>Here, IRF7 is induced in a RelA-dependent manner; this newly formed IRF7 binds and activates the RIG-I promoter, sustaining IFN-b (B) Expression of IL6, IL8, Grob, and MCP1 genes from the same experiment were quantified by qRT-PCR.</s><s>Shown is the fold-change in mRNA abundance normalized to cyclophilin (PPIA).</s><s>*p &lt; 0.01 compared to poly(I:C) only.</s><s>Data are the means ± SD from n = 3 experiments.</s><s>(C) hSAECs were transfected with 4 mg pCMV2 empty vector (control), BRD4WT, BRD4 kinase mutant (BRD4DN), or BRD4 HAT mutant (BRD4DHAT) expression vectors.</s><s>24 hr later, cells were fixed and stained with anti-H3K122 Ac rabbit Ab and anti-FLAG M2 mouse Ab.</s><s>Secondary detection was Alexa-568-conjugated goat anti-rabbit IgG (red, for H3K122ac) and 488-conjugated (green, for FLAG) goat anti-mouse IgG, respectively.</s><s>Nuclei were counterstained and images acquired as in (A).</s><s>(legend continued on next page) production.</s><s>We confirmed that this pathway is also activated by poly(I:C) and is blocked by the RelA CKO in bronchiolar epithelium (Figure <ref type="figure" target="#fig_4">S3</ref>).</s></p><p><s>In oil-treated animals, poly(I:C) stimulation produced a marked infiltration of neutrophils into the alveolar spaces and peribronchial regions (Figure <ref type="figure" target="#fig_5">4A</ref>).</s><s>By contrast, leukocytic inflammation was completely blocked in TMX-treated RelA CKO mice.</s><s>We next determined whether poly(I:C) induced BRD4 HAT activity.</s><s>In oil-treated mice challenged with PBS, only faint phospho-Ser 276 RelA signals were produced; poly(I:C) stimulation highly induced phospho-Ser 276 RelA in the bronchiolar epithelium of the oil-treated mice (Figure <ref type="figure" target="#fig_5">4A</ref>; quantitated in Figure <ref type="figure" target="#fig_5">4B</ref>).</s><s>By contrast, phospho-Ser 276 RelA staining was absent in TMXtreated RelA CKO , confirming staining specificity.</s></p><p><s>Examination of staining for H3K122 Ac showed a pattern of induction similar to that observed for phospho-Ser 276 RelA, with faint levels observed in PBS-treated WT airways and robust 21-fold induction of staining in the bronchiolar epithelium in response to poly(I:C) (Figures <ref type="figure" target="#fig_5">4A and 4B</ref>).</s><s>Strikingly, poly(I:C)induced activation of H3K122 Ac was effectively blocked by TMX treatment of RelA CKO .</s></p><p><s>Collectively, all of these data provide compelling evidence that activation of bronchiolar RelA is required for BRD4 HAT activity and poly(I:C)-induced airway inflammation.</s><s>We next sought to advance the use of small-molecule probes of BRD4 activity using small-molecule probes.</s></p><p><s>BRD4 Expression Is Required for Induction of the RelA-Dependent Gene Network First, to confirm that BRD4 expression mediates activation of poly(I:C)-induced gene regulatory networks, we observed that the robust, 120-fold increase in IL6 mRNA by poly(I:C) was reduced to less than 35-fold in BRD4 small interfering RNA (siRNA)-silenced cells (Figure <ref type="figure" target="#fig_5">S4</ref>).</s><s>Similarly, BRD4 siRNA silencing effectively blocked poly(I:C)-induced expression of CXCL2/Grob, CXCL8/IL8, CCL2/MCP1, and CCL5/RANTES mRNA (Figure <ref type="figure" target="#fig_5">S4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>BRD4 Bromodomain Interactions Are Required for Induction of the RelA-Dependent Gene Network</head><p><s>To determine whether disruption of BRD4-acetyl Lys interactions produced similar results as those produced by BRD4 depletion, we tested a panel of chemically unrelated BRD4 BD inhibitors on poly(I:C)-induced neutrophilic chemokine expression.</s><s>The inhibitors tested included the diazobenzene MS436 <ref type="bibr" target="#b42">(Zhang et al., 2013)</ref>, the amide JQ1 analog CPI203 <ref type="bibr" target="#b13">(Filippakopoulos et al., 2010)</ref>, the apabetalone RVX-208 <ref type="bibr" target="#b31">(Picaud et al., 2013)</ref>, and the dimethylsoxazole OXFBD2 <ref type="bibr" target="#b17">(Hewings et al., 2011)</ref>.</s><s>All produced a profound inhibition of poly(I:C)-induced IL6, CXCL8/IL8, and CXCL2/Grob mRNA expression (Figure <ref type="figure" target="#fig_5">S4</ref>).</s><s>These significant reductions in gene expression were confirmed by measurement of cytokine secretion in to the cell culture supernatant (Figure <ref type="figure" target="#fig_5">S4</ref>).</s><s>We conclude that BRD4 BD interactions are required for poly(I:C)-induced expression of RelA-dependent gene networks and neutrophilic chemokine secretion, making this an attractive target for small-molecule inhibition.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Development of Selective BRD4 Inhibitors Targeting the BD Domains</head><p><s>We therefore sought to design and synthesize BRD4 inhibitors with improved selectivity and drug-like properties.</s><s>The Kaci binding pocket in the BRD4 BD is anchored by the conserved residue Asn140 and Tyr97 and surrounded by a hydrophobic tripeptide tryptophan-proline-phenylalanine (WPF) shelf and linking domain ''ZA'' loop.</s><s>New BRD4 inhibitors, ZL0420 and ZL0454 (Figure <ref type="figure" target="#fig_6">5A</ref>), were designed by taking advantage of a substituted amino phenol moiety as the polar head of our ligand, diazene as the linker, and dihydroquinolin-2(1H)-one or N-cyclopentylbenzenesulfonamide as the binding tails to more efficiently fit into the BRD4 BD1 domain.</s><s>As depicted in Figures <ref type="figure" target="#fig_6">5B and 5C</ref>, docking studies demonstrated that these two inhibitors fit into the BRD4 BD1 in a similar binding mode.</s><s>Both compounds interact with Asn140 directly through the hydroxyl group of their phenol ring and form hydrogen bonds with Tyr97 mediated by a water molecule.</s><s>In addition, the phenyl ring of both molecules on their tails can form a T-shape p-p interaction with Trp81, while the diazene linker interacts with Lys91 mediated by water molecules.</s><s>These two inhibitors are sandwiched by the WPF shelf and residues from the ZA loop (Figure <ref type="figure" target="#fig_6">5D</ref>), thereby allowing strong interactions of the ligand and producing high binding affinity to the BRD4 BD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ZL Lead Compounds Are Potent and Highly Specific BRD4 Inhibitors</head><p><s>Despite significant effort invested in the development of smallmolecule BRD4 inhibitors, none have been reported that are highly selective for BRD4 over other members of the BET family <ref type="bibr" target="#b27">(Liu et al., 2017)</ref>.</s><s>To this end, by utilizing a structure-based drug design for the KAc binding pocket, ZL-0420 and ZL-0454, containing a dihydroquinolin-2(1H)-one or N-cyclopentyl-benzenesulfonamide binding tail, were synthesized.</s><s>Specificity for the BRD4 BDs was determined by time-resolved fluorescence energy transfer (TR-FRET) measurements versus the BDs from the closely related homolog, BRD2.</s><s>Strikingly, ZL-0420 and ZL-0454 display nanomolar binding affinities for BRD4 while exhibiting $30to 60-fold selectivity over BRD2 BDs (Figure <ref type="figure">6A</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ZL Lead Compounds Block Poly(I:C)-Induced Chemokine Expression and BRD4 HAT Activity In Vitro</head><p><s>We evaluated the effectiveness of the two ZL lead compounds for inhibiting poly(I:C)-induced innate immune response genes.</s><s>hSAECs were pretreated with a series of BRD4 inhibitors from (C) Validation of epithelial RelA CKO.</s><s>Co-staining of RelA (in green color) and the epithelium-specific marker Scgb1a (in red color) was performed using sections of paraffin-embedded lung of mice treated with oil (control) or TMX for 10 days.</s><s>(D) Quantification of total fluorescence intensities Scgb1a1 (CC10) and RelA staining.</s><s>*p &lt; 0.01; n = 5. (E) Total cells and neutrophils count in the bronchoalveolar lavage fluid (BALF), expressed as total number of cells 3 10 3 /mL (left) and percentage of neutrophils (right).</s><s>#p &lt; 0.01 compared with oil-treated mice; n = 5. (F) BALF cytokine secretion was measured using multiplex ELISA (n = 5 mice per group).</s><s>Protein concentration (in pg/mL) is shown.</s><s>*p &lt; 0.01; n = 5. 0.01 nM to 100 mM (final concentration) for 24 hr and stimulated with poly(I:C) (10 mg/mL, 4 hr), and innate gene expression of IL6 and RSAD2/CIG5 was determined by qRT-PCR.</s><s>These data showed that both ZL compounds have a submicromolar half maximal inhibitory concentration (IC 50 ) for inhibiting poly(I:C)induced expression of innate signaling and were more potent than either JQ1 <ref type="bibr" target="#b13">(Filippakopoulos et al., 2010)</ref> or RVX-208 <ref type="bibr" target="#b31">(Picaud et al., 2013)</ref> reference compounds (Figures <ref type="figure">6B and 6C</ref>).</s><s>Also, both ZL0420 and ZL0454 effectively blocked poly(I:C)-induced activation of H3K122Ac and formation of phospho-Ser2 CTD RNA Pol II (Figure <ref type="figure">6D</ref>; quantitated in Figure <ref type="figure">6E</ref>).</s><s>This selectivity profile indicates that our new inhibitors have a much higher BRD4 specificity than available reference molecules.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ZL Lead Compounds Disrupt BRD4 Binding to Pol II and Histones</head><p><s>To determine the mechanism of inhibition, we measured the effect of ZL0454 on BRD4 binding to Pol II and histones.</s><s>Soluble nuclear proteins were prepared from hSAECs pretreated with ZL0454 for 24 hr and subsequently stimulated with poly(I:C).</s><s>The BRD4 complex was captured by immunoprecipitation (IP) with anti-rabbit BRD4 antibody (Ab), and the complex was analyzed for the presence of BRD4, Pol II, H3, and H4 proteins quantified by stable isotope dilution (SID) selected reaction monitoring (SRM) mass spectrometry (MS), normalized by the input protein concentration <ref type="bibr" target="#b37">(Tian et al., 2013;</ref><ref type="bibr" target="#b44">Zhao and Brasier, 2013)</ref>.</s><s>A schematic of the SRM assays is shown in Figure <ref type="figure">6F</ref>.</s><s>BRD4 abundance was measured using two independent proteotypic peptides, BRD4-638 and BRD4-717 (Table <ref type="table">S2</ref>).</s><s>Compared to control immunoglobulin G (IgG) IPs, where the BRD4 abundance was completely undetectable, BRD4 was significantly enriched in the samples immunoprecipitated with anti-BRD4 Ab (Figure <ref type="figure">6F</ref>).</s><s>We detected a strong increase in BRD4 signals in the immunoprecipitated samples of ZL0454-pretreated hSAECs, indicating an increase of soluble fraction of BRD4 in the nucleoplasm released from the insoluble chromatin (Figure <ref type="figure">6G</ref>).</s><s>More importantly, poly(I:C) stimulation increased the association of BRD4 with Pol II, H3, and H4, and the effect of poly(I:C) was completely blocked with ZL0454 pretreatment (Figure <ref type="figure">6G</ref>).</s><s>We therefore conclude that ZL BD inhibitors disrupt BRD4 binding to Pol II and histones, releasing it from chromatin into the soluble fraction of the nucleoplasm.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In Vivo Effect of ZL0420 and ZL0454 on Poly(I:C)-Induced Airway Inflammation</head><p><s>We evaluated the effectiveness of the lead inhibitors (ZL-0420 and ZL-0454) in blocking acute poly(I:C)-induced airway inflammation in vivo.</s><s>Histologically, we observed that poly(I:C) induced a profound neutrophilic inflammation around the small and medium-sized airways 24 hr after poly(I:C) stimulation that was completely inhibited by ZL inhibitor administration <ref type="bibr">(Figure 7A,</ref><ref type="bibr">top)</ref>.</s><s>ZL inhibitors also effectively blocked poly(I:C)-induced activation of H3K122 Ac, a selective marker of the activated BRD4 HAT and formation of phospho-Ser2 CTD RNA Pol II (Figure <ref type="figure">7A</ref>; quantitated in Figure <ref type="figure">7B</ref>).</s><s>Furthermore, ZL inhibitors prevented poly(I:C)-induced mRNA expression of the NF-kB/RelA-dependent genes IL6, KC, CXCL2/Grob, CCL2/MCP1, and CCL5/ RANTES as well as IFNb in the mouse lung tissue (Figure <ref type="figure">7C</ref>).</s><s>Meanwhile, ZL inhibitors also induced HEXIM1 expression, indicating that these compounds interacted with BRD4 in mouse lung tissue (Figure <ref type="figure" target="#fig_6">S5</ref>) <ref type="bibr" target="#b14">(Fiskus et al., 2014)</ref>.</s></p><p><s>The number of leukocytes in the BALF of poly(I:C)-treated mice increased $6 times compared to that of PBS-treated mice, an induction completely inhibited by treatment with either ZL compound (Figure <ref type="figure">7D</ref>, left).</s><s>Also, we observed the percentage of BALF neutrophils that increased from 1% to 62.4% in PBStreated mice exposed to poly(I:C) was reduced to 11.7% and 8.2%, respectively, in ZL0420-and ZL0454-treated mice (Figure 7D right panel).</s><s>Meanwhile, we also observed that ZL inhibitors effectively suppress poly(I:C)-induced inflammatory cytokine secretion in the BALF (Figure <ref type="figure">7E</ref>).</s><s>Collectively, these findings provide strong evidence that BRD4 is required for poly(I:C)-induced inflammation and that the ZL inhibitors are efficacious in vivo.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Viral infections are responsible for unscheduled hospital visits, prolonged recovery time, and accelerated loss of pulmonary function in patients with COPD <ref type="bibr" target="#b10">(Donaldson et al., 2002;</ref><ref type="bibr" target="#b34">Seemungal et al., 1998)</ref>.</s><s>One mechanism is that viruses promote exacerbations by triggering host inflammatory responses resulting in cellular infiltration, mucous production, airway hyperreactivity, and remodelling <ref type="bibr" target="#b41">(Wedzicha, 2004)</ref>.</s><s>Using poly(I:C) as a prototypical viral PAMP that mimics the inflammatory exacerbations of COPD <ref type="bibr" target="#b15">(Harris et al., 2013)</ref>, we examined the role of the Scgb1a1-expressing tracheobronchiolar epithelial cell as an innate sentinel cell and, specifically, the role of the NF-kB-BRD4 pathway in mediating airway inflammation.</s><s>Our findings that selective depletion of RelA in tracheal and bronchiolar epithelial cells prevented BRD4 activation and poly(I:C)-induced expression of inflammatory cytokines and IFNs indicate that epithelial cells are a major sensor of luminal poly(I:C).</s><s>Two highly selective BRD4 small-molecule antagonists disrupt the BRD4 complex and consequently block viral inflammatory gene programs in vitro and airway inflammation in vivo.</s><s>Together, these data indicate that the bronchiolar epithelial NF-kB-BRD4 complex plays a primary role in acute neutrophilic response to viral molecular patterns.</s></p><p><s>The pulmonary mucosal innate defense is coordinated by a complex interaction between resident epithelial cells, alveolar macrophages, innate lymphoid cells, and other innate leukocytes <ref type="bibr" target="#b18">(Holt and Strickland, 2010)</ref>.</s><s>Epithelial cells are a dynamically responsive and structurally diverse population of cells that play essential roles in host defense by forming a semi-impermeable barrier, clearing inhaled microparticles by the ciliary escalator, secreting antiviral mucins and expressing antiviral cytokines <ref type="bibr" target="#b24">(Lambrecht and Hammad, 2012)</ref>.</s><s>Despite this understanding, the relative contributions of epithelial versus other sentinel cells of the airways (macrophages, innate epithelial lymphocytes, natural killer [NK] cells, and others) have not been definitely established.</s><s>Here, we demonstrate that a Scgb1a1/CC10-expressing lineage of epithelial cells represents the major sensor of viral patterns in the airway lumen.</s><s>Scgb1a1 is selectively expressed in distal bronchial and bronchiolar epithelial Clara cells, a dynamic population of basal (nonciliated) epithelial cells that play important roles in xenobiotic metabolism and as stem cell precursors to repopulate the postnatal airway after injury <ref type="bibr" target="#b33">(Rawlins et al., 2009)</ref>.</s></p><p><s>Our studies extend the function of the Scgb1a1-expressing Clara cell as an innate sensor and mediator of the antiviral response.</s><s>It is interesting that diverse phenotypes of airway epithelial cells express the TLR3 pattern recognition receptors on their luminal surface and respond to extracellular dsRNA, in contrast to neutrophils, which lack TLR3 expression <ref type="bibr" target="#b16">(Hayashi et al., 2003)</ref>.</s><s>Consequently neutrophil recruitment is an indirect process, primarily mediated by epithelial secretion of neutrophilic chemokines.</s><s>Given this observation, why would depletion of NF-kB/RelA selectively in this tracheobronchial cell population have such a dramatic effect on airway inflammation?</s><s>One explanation may be provided by our systems-level proteomics studies that have shown cell-type differences in innate cytokine production in response to RSV infection.</s><s>Here, we observed that although a significant amount of proteins were shared between tracheal and bronchiolar cells, the bronchiolar cells selectively secreted TSLP, CCL20, and IL-6, proteins that promote Th2 and mucin expression, which is important in the pathogenesis of RSV-induced lower respiratory tract infections <ref type="bibr" target="#b45">(Zhao et al., 2017)</ref>.</s><s>These subtle differences in chemokine expression patterns by different epithelial cell types are therefore immunologically significant.</s></p><p><s>Our experimental approach using a TMX-inducible conditional RelA CKO in the Scgb1a1-expressing cell is distinct from several studies that have used the Scgb1a1 promoter to inhibit the canonical NF-kB pathway in airway inflammation and fibrosis in dust mite allergen exposure <ref type="bibr" target="#b40">(Tully et al., 2013)</ref>.</s><s>Expression of NF-kB mediates rapid genomic responses by recruiting transcriptional elongation complexes to immediate early genes <ref type="bibr">(Brasier et al., 2011)</ref>.</s><s>Viral PAMPs induce reactive oxygen species (ROS) production that interfaces with DNA damage response pathways to produce Ser phosphorylation of RelA, a post-translational modification coupled with Lys acetylation that promotes complex formation with BRD4 <ref type="bibr">(Brasier et al., 2011;</ref><ref type="bibr" target="#b46">Zou et al., 2014)</ref>.</s><s>BRD4 is an acetylated Lys reader containing intrinsic kinase activity <ref type="bibr">(Devaiah et al., 2012</ref>) that bridges RelA with CDK9 of the positive transcriptional elongation complex <ref type="bibr" target="#b21">(Jang et al., 2005)</ref>.</s><s>Phosphorylation on Ser2 of RNA Pol II CTD is a key regulatory step in the activation of NF-kB-dependent genes by transcriptional elongation.</s><s>Our findings that global Ser2 CTD RNA Pol II activation requires both activated RelA and BRD4 suggests that the RelA-BRD4 complex may be a global genome regulatory complex.</s><s>Our data demonstrating that BRD4 is required for serine phosphorylation of RNA Pol II is consistent with earlier findings showing BRD4 mediates innate signaling by cytokines <ref type="bibr" target="#b19">(Huang et al., 2009)</ref> and RNA viruses <ref type="bibr" target="#b39">(Tian et al., 2017)</ref>.</s></p><p><s>In addition, BRD4 is an atypical HAT producing H3 K122 Ac, a modification that reduces histone side charge and enables RNA Pol II to transcribe through GC-rich regions of innate immune response genes, an independent effect on transcriptional elongation <ref type="bibr" target="#b9">(Devaiah et al., 2016)</ref>.</s><s>Our data show that BRD4 HAT activity is upregulated by activated RelA downstream of diverse innate stimuli.</s><s>Our transient transfection studies, interpreted with the effects of our selective BRD4 BD inhibitors both suggest that the H3K122 acetyltransferase requires BRD4 HAT activity.</s><s>Previous work has shown that H3K122 acetylation is independent of p300/CREB-binding protein (CBP) acetyltransferases <ref type="bibr" target="#b9">(Devaiah et al., 2016)</ref>.</s><s>Because RelA lacks any known enzymatic activity, the RelA-dependent activation of BRD4 HAT must be indirect.</s><s>Our previous experimental and computational work has identified 900 proteins that interact with RelA and modify its activity <ref type="bibr" target="#b25">(Li et al., 2014;</ref><ref type="bibr" target="#b43">Zhang et al., 2017)</ref>, and the identification of those responsible for activating BRD4 HAT will require further work.</s></p><p><s>Because of its diverse roles in inflammation, cancer, and fibrosis, the development of BRD4 inhibitors has been the subject of intense focus <ref type="bibr" target="#b27">(Liu et al., 2017)</ref>.</s><s>In this study, we applied structure-based drug design to advance the pharmacopeia of BRD4 inhibitors.</s><s>Our small-molecule inhibitors demonstrate enhanced potency and selectivity for both BDs of BRD4, but not for the closely related BRD2 isoform.</s><s>More detailed structure-function relationship studies will be required to understand this BD preference.</s><s>BRD4 forms protein-protein interactions via BDs <ref type="bibr" target="#b19">(Huang et al., 2009)</ref> and its COOH extra-terminal domain <ref type="bibr" target="#b22">(Jonkers and Lis, 2015)</ref>.</s><s>Our recent unbiased proteomics studies demonstrate that BRD4 is a hub signaling protein that complexes with the AP2 adaptor switch/sucrose non-fermentable (SWI/SNF) and the DNA-directed RNA Pol II complex <ref type="bibr" target="#b43">(Zhang et al., 2017)</ref>.</s><s>Here, we demonstrate the mechanism of inhibition of BD-directed inhibitors.</s><s>Affinity purification SID-SRM studies demonstrate that the BRD4 inhibitors disrupt not only BRD4 from its tight association with chromatin and the histone H3/H4 interaction but also BRD4 binding with RNA Pol II.</s><s>Earlier work has shown that the BRD4 BD is required for the interaction with acetylated RelA <ref type="bibr" target="#b46">(Zou et al., 2014)</ref>.</s><s>Further studies are in progress to systematically identify what components of the BRD4 interactome require binding to the BD.</s></p><p><s>The ZL compound forms extensive and strong interactions with the BRD4 BD1, including direct and multiple H 2 O-mediated indirect hydrogen bond networks, p-p interactions, and hydrophobic contacts.</s><s>By contrast, very limited interactions were observed for BRD2 BD1.</s><s>In molecular docking experiments, the ZL NH2 was rotated where it formed a single hydrogen bond with Pro98, and no direct or indirect hydrogen bonds were seen.</s><s>Hydrophobic contacts were observed with Asn156.</s><s>In this conformation, the hydrophobic tail of ZL was away from the WPF shelf.</s><s>Such differences in key interactions may explain the selectivity of the ZL compound for BRD4 over other relevant proteins (BRD2, BRD3, and BRDT).</s></p><p><s>Using these unique molecular probes, we were able to elucidate the biological roles of BRD4 in vivo.</s><s>The effect of our selective inhibitors to block H3K122 Ac and inflammation validate BRD4 as a target for the treatment of acute lung inflammation mediated by viral PAMPs triggering the RIG-I and the TLR3 pathway.</s><s>Recently, we discovered the important role of the RelA-BRD4 pathway in controlling growth-factor-induced mesenchymal transition, airway remodelling, and airway fibrosis <ref type="bibr" target="#b38">(Tian et al., 2016</ref><ref type="bibr" target="#b39">(Tian et al., , 2017))</ref>.</s><s>Further work will be needed to determine whether BRD4 inhibitors are effective in reducing airway remodelling as a consequence of repetitive viral exposures.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EXPERIMENTAL PROCEDURES</head><p><s>A complete description of experimental procedures is found in Supplemental Experimental Procedures.</s></p><p><s>Efficacy of BRD4 Inhibitors in Acute Poly(I:C)-Induced Airway Inflammation Animal experiments were performed according to the NIH Guide for Care and Use of Experimental Animals and approved by the University of Texas Medical Branch (UTMB) Animal Care and Use Committee (approval 1312058A).</s><s>Male C57BL6/J mice (18 weeks old) were purchased from The Jackson Laboratory (Bar Harbor, ME) and housed under pathogen-free conditions with food and water ad libitum.</s><s>C57BL/6 mice were pretreated in the absence or presence of the indicated BRD4 inhibitor (50 mg/kg body weight, via the intraperitoneal [i.p.] route) 1 day prior to poly(I:C) stimulation.</s><s>The next day, mice were given another dose of BRD4 inhibitor immediately followed by intranasal (i.n.) administration of PBS (50 mL) or poly(I:C) (100 mg dissolved in 50 mL PBS). 1 day later, the mice were euthanized.</s><s>For bronchoalveolar lavage (BAL), the trachea was cannulated and 1 mL PBS was introduced by syringe.</s><s>The BALF was analyzed for total and differential cell counts and quantified for secreted cytokines/chemokines using multiplex immunoassays (BioPlex).</s><s>Half of each lung was fixed with 10% (v/v) neutral buffered formalin for 3 days, processed into paraffin blocks, and cut into 5-mm sections for H&amp;E staining.</s><s>The other half of each lung was immediately frozen in liquid N 2 and pulverized. 1 mL Tri Reagent was added, followed by the extraction of total RNA as per the manufacturer's directions.</s><s>Total RNA was reverse transcribed and gene expression quantified using qRT-PCR <ref type="bibr" target="#b39">(Tian et al., 2017)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evaluation of Airway Inflammation</head><p><s>Lungs were perfused twice with 0.75 mL sterile PBS (pH 7.4) to obtain BALF.</s><s>Total cell counts were determined by trypan blue staining 50 mL BALF and counting viable cells using a hemocytometer.</s><s>Differential cell counts were performed on cytocentrifuge preparations (Cytospin 3; Thermo Shandon, Pittsburgh, PA) stained with Wright-Giemsa.</s><s>A total of 300 cells were counted per sample using light microscopy.</s><s>Formalin-fixed lungs were embedded in paraffin, sectioned at 4 mm thickness, and stained with H&amp;E or Masson's trichrome.</s><s>Microscopy was performed on a NIKON Eclipse Ti System <ref type="bibr" target="#b38">(Tian et al., 2016)</ref>.</s><s>Statistical Analysis A one-way ANOVA was performed for time differences, followed by Tukey's post hoc test to determine significance.</s><s>Mann-Whitney tests were used for nonparametric data.</s><s>All data subjected to statistical analysis are the mean ± SD.</s><s>A p value &lt;0.05 was considered significant.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>RelA Mediates Poly(I:C)-Stimulation-Induced BRD4 Activation</s></p></div></figDesc><graphic coords="4,61.91,101.60,485.95,506.83" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>(</head><label></label><figDesc><div><p><s>A) RelA deletion was performed by targeting a 20-nt seed sequence in exon 4 of the RelA gene, introducing a stop codon that induces nonsense-mediated RNA decay.</s><s>The seed sequence is in blue; exons are indicated in orange.</s><s>(B) Western blot of RelA expression in wild-type (control) and CRISPR/Cas9 genome-edited cells.</s><s>NS, nonspecific band.</s><s>(C) Wild-type (control) and CRISPR/Cas9 genome-edited hSAECs were challenged with poly(I:C) (10 mg/mL) for 0 and 6 hr.</s><s>Expression of CSF3/G-CSF, CSF2/ GM-CSF, CXCL1/Groa, CXCL2/Grob, CXCL8/IL8, CCL2/MCP1, and CCL5/RANTES was quantified by q RT-PCR.</s><s>Shown is the fold-change in mRNA abundance normalized to cyclophilin (PPIA).</s><s>*p &lt; 0.01 compared to control hSAECs; n = 3. (D) Cells were stimulated with poly(I:C).</s><s>After fixation, cells were stained with primary Abs of RelA, phospho-Ser 276 RelA, H3K122ac, and phospho-Ser 2 CTD RNA Pol II.</s><s>Secondary detection was Alexa-488-(green, for RelA and p276 RelA), 568-(red, for pPol II), and 647-conjugated (deep red, for H3K122ac) goat antirabbit IgG, respectively.</s><s>Nuclei were counterstained with DAPI (blue).</s><s>Images were acquired by confocal microscopy at 633 magnification.</s><s>(E) Quantification of total fluorescence intensities is shown as fold changes compared to WT hSAECs.</s><s>*p &lt; 0.01; n = 5.</s><s>FI, relative total fluorescence intensity.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. BRD4 Is Required for Acetylation of H3K122 and Cooperates with CDK9 for Inducible Phosphorylation of the RNA Pol II CTD (A) hSAECs were transfected with scrambled siRNA (control), BRD4-specific siRNA, or CDK9-specific siRNA (100 nM).</s><s>48 hr later, cells were stimulated with extracellular poly(I:C) for 4 hr.</s><s>After fixation, cells were stained with anti-H3K122ac and anti-phospho-Ser 2 CTD RNA Pol II Abs as indicated.</s><s>Secondary detection was Alexa-568-(red, for H3K122ac) and 488-conjugated (green, for pPol II) goat anti-rabbit IgGs.</s><s>Images were acquired by confocal microscopy at 633 magnification.</s></p></div></figDesc><graphic coords="5,90.26,101.59,415.89,572.66" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc><div><p><s>(D) Transient transfectants were stained with anti-phospho-Ser 2 CTD RNA Pol II rabbit Ab and anti-FLAG M2 mouse Ab.</s><s>Secondary detection, nuclear counterstaining, and image acquisition are as in (C).</s><s>(E) Expression of IL6, IL8, and Grob were quantified by qRT-PCR.</s><s>*p &lt; 0.01 compared to BRD4WT transfectants.</s><s>Data are the means ± SD from n = 3 experiments.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Conditional Knockout of RelA Non-ciliated Epithelial Clara Cells (A) Strategy for generating conditional knockout of RelA in non-ciliated epithelial Clara cells.</s><s>RelA fl/fl conditional knockout (CKO) were crossed with an epithelialspecific secretoglobin family 1A member 1 (Scgb1a1) promoter-driven inducible Cre recombinase/estrogen receptor fusion protein (CreER TM ) transgenic mouse in the C57BL6/J background.</s><s>Scgb1a1-CreER TM 3 RelA fl/fl mice were injected (i.p.) with oil or tamoxifen (TMX) for 10 days for epithelial RelA knockout.</s><s>(B) The Scgb1a1-CreER TM 3 RelA fl/fl mice crossed with the dimeric tomato (mT)/membrane EGFP (mG) mouse and exposed to vehicle oil or TMX for 10 days; 2 weeks later, the lungs were analyzed by IFCM.</s><s>Note that membrane-localized EGFP (green signal) was observed in TMX-treated mice.</s></p></div></figDesc><graphic coords="7,89.01,101.59,418.28,562.28" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. Bronchiolar RelA Is Required for Poly(I:C)-Induced Inflammation In Vivo Scgb1a1/CC10 -Cre 3 RelA CKO mice were pretreated with oil (control) or TMX 21 days prior to experimentation.</s><s>For poly(I:C) challenge, mice were administered either 50 mL PBS or 50 mL PBS + 100 mg poly(I:C) via the i.n.</s><s>route.</s><s>(A) H&amp;E staining (top), immunofluorescence staining of phospho-276 RelA (middle, red), and immunofluorescence staining of H3K122 Ac (bottom, green) were performed on paraffin-embedded lung sections.</s><s>(B) Quantification of total fluorescence intensity on immunofluorescence staining of phospho-276 RelA and H3K122 Ac. *p &lt; 0.01; n = 5.</s></p></div></figDesc><graphic coords="9,53.12,101.71,322.79,180.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 5 .</head><label>5</label><figDesc><div><p><s>Figure 5. Design and Structures of Novel BRD4 Inhibitors ZL0420 and ZL0454 (A) Chemical structures of the novel BRD4 inhibitors ZL0420 and ZL0454.</s><s>(B) Binding mode of ZL0420 (yellow) with BRD4 BD1 in ribbon representation.</s><s>The highlighted residues are Asn140 (N140), Tyr97 (Y97), Pro82 (P82), Trp81 (W81), and Lys91 (K91).</s><s>(C) Binding mode of ZL0454 (magenta) with BRD4 BD1 in ribbon representation.</s><s>(D) Superimposition of ZL0420 (green) and ZL0454 (yellow) docked into BRD4 BD1 in the form of surface representation.</s><s>The WPF (Trp81-Pro82-Phe83) shelf is highlighted in magenta, and part of the ZA loop is colored orange.</s><s>Asn, asparagine; Tyr, tyrosine; Pro, proline; Trp, tryptophan; Lys, lysine.</s></p></div></figDesc><graphic coords="10,59.75,101.71,322.79,283.81" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="1,55.16,194.51,285.82,285.68" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="11,132.32,101.60,331.91,488.01" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="12,128.52,101.59,352.77,487.56" type="bitmap" /></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>the nondegradable IkÀBa ''super-repressor'' selectively inhibits canonical pathway activation but does not affect the cross-talk pathway <ref type="bibr" target="#b3">(Brasier, 2006)</ref>.</s><s>It is important to recognize that NF-kB activation by viral patterns involves both the canonical and cross-talk pathways <ref type="bibr" target="#b26">(Liu et al., 2008)</ref>; our RelA CKO strategy interferes with both.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DECLARATION OF INTERESTS</head><p><s>The authors declare no competing interests.</s></p><p><s>Received: August 2, 2017 Revised: <ref type="bibr">February 11, 2018</ref><ref type="bibr">Accepted: March 22, 2018</ref><ref type="bibr">Published: April 24, 2018</ref></s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3</title>
		<author>
			<persName><forename type="first">L</forename><surname>Alexopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Holt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Medzhitov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Flavell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">413</biblScope>
			<biblScope unit="page" from="732" to="738" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">NF-kappaB activation limits airway branching through inhibition of Sp1-mediated fibroblast growth factor-10 expression</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Benjamin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Carver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Plosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Van Der Meer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Blackwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Prince</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="page" from="4896" to="4903" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Dynamic cross talk model of the epithelial innate immune response to double-stranded RNA stimulation: coordinated dynamics emerging from cell-level noise</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bertolusso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Vergara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sabree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Iwanaszko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lipniacki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kimmel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e93396</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The NF-kappaB regulatory network</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc. Toxicol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="111" to="130" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jamaluddin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Kalita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Garofalo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lu</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection</title>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="11752" to="11769" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Deaths from chronic obstructive pulmonary disease-United States</title>
	</analytic>
	<monogr>
		<title level="j">Centers for Disease Control and Prevention (CDC)</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="1229" to="1232" />
			<date type="published" when="2000">2008. 2000-2005</date>
		</imprint>
	</monogr>
	<note>MMWR Morb. Mortal. Wkly. Rep.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Devaiah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Singer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="page" from="38755" to="38766" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Devaiah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Cherman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Hewitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Albrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Robey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ozato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Sims</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Singer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="6927" to="6932" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Devaiah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Case-Borden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gegonne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Meerzaman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ozato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Singer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Struct. Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="540" to="548" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Donaldson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Seemungal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bhowmik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Wedzicha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thorax</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="847" to="852" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Airway and systemic inflammation and decline in lung function in patients with COPD</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Donaldson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Seemungal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bhowmik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Wilkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Hurst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Maccallum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Wedzicha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<date type="published" when="1995">2005. 1995-2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Ataxia telangiectasia mutated kinase mediates NF-kB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection</title>
		<author>
			<persName><forename type="first">L</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Choudhary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Boldogh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ivanciuc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Garofalo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="2628" to="2642" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Selective inhibition of BET bromodomains</title>
		<author>
			<persName><forename type="first">P</forename><surname>Filippakopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Picaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Fedorov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Morse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Keates</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Hickman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Felletar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">468</biblScope>
			<biblScope unit="page" from="1067" to="1073" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD</title>
		<author>
			<persName><forename type="first">W</forename><surname>Fiskus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Devaraj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Leveque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Portier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Iyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Bradner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Bhalla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cancer Ther</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="2315" to="2327" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Double-stranded RNA induces molecular and inflammatory signatures that are directly relevant to COPD</title>
		<author>
			<persName><forename type="first">P</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sridhar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Cohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Burns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Woods</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ramanujam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Loubeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tyagi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mucosal Immunol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="474" to="484" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Toll-like receptors stimulate human neutrophil function</title>
		<author>
			<persName><forename type="first">F</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Means</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Luster</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="2660" to="2669" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Hewings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Philpott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Fedorov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Uttarkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Filippakopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Picaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vuppusetty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Marsden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Knapp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="6761" to="6770" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Interactions between innate and adaptive immunity in asthma pathogenesis: new perspectives from studies on acute exacerbations</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Holt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Strickland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Allergy Clin. Immunol</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="973" to="974" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA</title>
		<author>
			<persName><forename type="first">B</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">D</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ozato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell. Biol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1375" to="1387" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Generation and characterization of a novel transgenic mouse harboring conditional nuclear factor-kappa B/RelA knockout alleles</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ijaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wakamiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Recinos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Tilton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Dev. Biol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">32</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mochizuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Jeong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Brady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ozato</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="523" to="534" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Getting up to speed with transcription elongation by RNA polymerase II</title>
		<author>
			<persName><forename type="first">I</forename><surname>Jonkers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Lis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="167" to="177" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Alveolar macrophages contribute to the pathogenesis of hMPV infection while protecting against RSV infection</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kolli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sbrana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Velayutham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Casola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Garofalo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Respir. Cell Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="502" to="515" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">The airway epithelium in asthma</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Lambrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hammad</forename></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="684" to="692" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Modulation of gene expression regulated by the transcription factor NF-kB/RelA</title>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jamaluddin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rowicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kudlicki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="11927" to="11944" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-Imiddle dotNF-kappa B-inducing kinase signaling pathway</title>
		<author>
			<persName><forename type="first">P</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Garofalo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">283</biblScope>
			<biblScope unit="page" from="23169" to="23178" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Drug discovery targeting bromodomain-containing protein 4</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Wold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="4533" to="4558" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">A global double-fluorescent Cre reporter mouse</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Muzumdar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tasic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miyamichi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Luo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genesis</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="593" to="605" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Nowak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jamaluddin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Boldogh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Vergara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Choudhary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell. Biol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="3623" to="3638" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Peebles</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jarzecka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Furlong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Sheller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Graham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Infect. Dis</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="page" from="1374" to="1379" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain</title>
		<author>
			<persName><forename type="first">S</forename><surname>Picaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wells</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Felletar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Brotherton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Savitsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Diez-Dacal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Philpott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bountra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lingard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="19754" to="19759" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Rabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hurd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Anzueto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Buist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Calverley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fukuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jenkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rodriguez-Roisin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Van Weel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zielinski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Respir. Crit. Care Med</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="532" to="555" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>Global Initiative for Chronic Obstructive Lung Disease</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Rawlins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Okubo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Brass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Auten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Hogan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Stem Cell</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="525" to="534" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Seemungal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Donaldson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Bestall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Jeffries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Wedzicha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Respir. Crit. Care Med</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="1418" to="1422" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Stowell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Seideman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Raymond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Smalley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Lamb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Egenolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Bugelski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Marsters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bunting</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Respir. Res</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">43</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Identification of direct genomic targets downstream of the nuclear factor-kap-paB transcription factor mediating tumor necrosis factor signaling</title>
		<author>
			<persName><forename type="first">B</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Nowak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jamaluddin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="17435" to="17448" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells</title>
		<author>
			<persName><forename type="first">B</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kalita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Edeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Paessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Casola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Teng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Garofalo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="7075" to="7092" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">BRD4 mediates NF-kB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation</title>
		<author>
			<persName><forename type="first">B</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Physiol. Lung Cell. Mol. Physiol</title>
		<imprint>
			<biblScope unit="volume">311</biblScope>
			<biblScope unit="page" from="L1183" to="L1201" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Bromodomain containing 4 (BRD4) couples NFkB/RelA with airway inflammation and the IRF-RIG-I amplification loop in respiratory syncytial virus infection</title>
		<author>
			<persName><forename type="first">B</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ivanciuc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Garofalo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
		<idno type="DOI">10.1128/JVI.00007-00017</idno>
		<ptr target="https://doi.org/10.1128/JVI.00007-00017" />
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<date type="published" when="2017-01-11">2017. January 11, 2017</date>
		</imprint>
	</monogr>
	<note>Published online</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Epithelial NF-kB orchestrates house dust mite-induced airway inflammation, hyperresponsiveness, and fibrotic remodeling</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Tully</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Hoffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Lahue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Nolin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Anathy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K A</forename><surname>Lundblad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Daphtary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Aliyeva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Black</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Dixon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="page" from="5811" to="5821" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Role of viruses in exacerbations of chronic obstructive pulmonary disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Wedzicha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Am. Thorac. Soc</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="115" to="120" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains</title>
		<author>
			<persName><forename type="first">G</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Plotnikov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rusinova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Morohashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Joshua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mujtaba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ohlmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M.-M</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="9251" to="9264" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Quantitative assessment of the effects of trypsin digestion methods on affinity purificationmass spectrometry-based protein-protein interaction analysis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Proteome Res</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="3068" to="3082" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Applications of selected reaction monitoring (SRM)-mass spectrometry for quantitative measurement of signaling pathways</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="313" to="322" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Systematic analysis of cell-type differences in the epithelial secretome reveals insights into the pathogenesis of respiratory syncytial virus-induced lower respiratory tract infections</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jamaluddin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ivanciuc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Garofalo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">198</biblScope>
			<biblScope unit="page" from="3345" to="3364" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Brd4 maintains constitutively active NF-kB in cancer cells by binding to acetylated RelA</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Zou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bradner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="2395" to="2404" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
